Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VB-201 in moderate to severe plaque psoriasis
NCT01001468Phase 2Completed
- Sponsor
- VBL Therapeutics
- Start
- Dec 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of VB-201 in plaque psoriasis, sponsored by VBL Therapeutics. Started Dec 2009; status: completed.
02
Drugs
VB-201
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01001468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001468.